Abstract
Resistant hypertension, defined as the failure to achieve target blood pressure despite concurrent use of 3 antihypertensive agents of different classes, is estimated to affect 20-30% of hypertensive patients. These patients are vulnerable to cardiovascular, cerebrovascular and renal complications. There is ample evidence that sympathetic nervous system hyperactivity contributes to the initiation, maintenance and progression of hypertension. The renal sympathetic nervous system, in particular, has been identified as a major culprit for the development and progression of hypertension, heart failure and chronic kidney disease in both preclinical and human studies. Traditional surgical sympathectomy proposed in 1940s was halted due to unacceptable operative risk and the emergence of anti-hypertensive medications. Recently, catheter-based renal sympathetic denervation by radiofrequency ablation has shown encouraging intermediate-term results with minimal complications in patients with resistant hypertension. This review summarizes the patho-physiological role of the renal sympathetic nervous system and the potential application of renal denervation therapy for the treatment of resistant hypertension.
References
May 1, 1992·Blood Pressure·S JuliusO Andersson
May 1, 1992·Canadian Journal of Physiology and Pharmacology·L BarajasK Powers
Mar 15, 1992·Annals of Internal Medicine·M EslerI Willett
Aug 1, 1989·Hypertension·E A AndersonA L Mark
Jul 1, 1981·Pflügers Archiv : European journal of physiology·U KoppB Ablad
Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
Feb 20, 2002·JAMA : the Journal of the American Medical Association·JoAnne Micale FoodyHarlan M Krumholz
Oct 9, 2002·Circulation·Martin HausbergKarl Heinz Rahn
Mar 8, 2003·Hypertension·Gerald F DiBona
Jul 9, 2003·Circulation·Markus P SchlaichMurray D Esler
Jun 25, 2008·Circulation·David A CalhounUNKNOWN American Heart Association Professional Education Committee
Apr 1, 2009·Lancet·Henry KrumMurray Esler
Nov 26, 2010·Lancet·UNKNOWN Symplicity HTN-2 InvestigatorsMichael Böhm
Jan 26, 2011·Neurology·N K PatelJ F R Paton
Mar 16, 2011·Hypertension·UNKNOWN Symplicity HTN-1 Investigators
Apr 20, 2011·Hypertension·Stephen D Persell
Apr 27, 2011·Circulation·Felix MahfoudMichael Böhm
Aug 17, 2011·Hypertension·Adam WitkowskiAndrzej Januszewicz
Citations
Dec 1, 2012·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·W L VerloopP A Doevendans
Jul 23, 2014·Clinical and Experimental Hypertension : CHE·Huijie LiChengming Yang
Apr 26, 2016·International Journal of Cardiology·Katsunori NonogakiNariki Kubota
Jan 25, 2014·International Journal of Cardiology·Hitesh C Patel, Tushar V Salukhe
Dec 18, 2013·International Journal of Cardiology·E ImbalzanoA Saitta
Feb 20, 2013·International Journal of Cardiology·Katsunori NonogakiNariki Kubota
Apr 5, 2014·International Journal of Cardiology·E ImbalzanoA Saitta
Feb 14, 2015·European Journal of Internal Medicine·Lene Kjær OlsenBo Feldt-Rasmussen
Jan 10, 2014·Angiology·Thomas D GossiosHaralambos Karvounis
Jan 4, 2013·The Journal of Clinical Hypertension·Priyanka GosainRajender Agarwal